You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The Chinese firms have agreed to work together to develop commercial analytical and artificial intelligence-based computing platforms for single-cell genomics.
As researchers embrace single-nucleus analysis to probe previously intractable tissues, companies are trying to deliver more reliable sample preparation.
The Seattle-based University of Washington spinout is planning to scale up the commercial roll-out of its single-cell, whole-transcriptome assay kit.
For the three months ended Sept. 30, the company reported $71.8 million in revenues, up from $61.2 million in Q3 2019 and beating the average Wall Street estimate.
Translational informatics company Paradigm4's new Reveal: SingleCell app is built on its core SciDB platform that supports fast querying of large multiomic datasets.
Researchers combined protein expression with mutational analysis to map the somatic genotype and clonal architecture of AML with its immunophenotype.
D-Mark will help promote, sell, and support S2's Singulator 100 system and associated products for single-cell genomics and cell biology applications.
Researchers from the Broad Institute and MIT have used RNA editing and single-cell RNA sequencing to record when RNA molecules were transcribed.
The Tokyo-based firm is looking to expand into the US market following a recent ¥700 million ($6.6 million) Series B financing round.
The firm is offering an additional 500,000 shares of Class A stock, bringing the total to 4 million shares, offered at $110 per share.
Nature News writes that viral genomic surveillance in the US faces systemic issues.
President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.
A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.
In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.